Bone marrow-derived stem cells may offer novel therapeutic option for skin disorder
Thursday, December 4, 2008 - 13:30
in Health & Medicine
Stem cells derived from bone marrow may serve as a novel therapeutic option to treat a disease called epidermolysis bullosa (EB), a disorder characterized by extraordinarily fragile skin, according to a study prepublished online in Blood, the official journal of the American Society of Hematology.